Analysis of the Medicinal and Recreational use of Leonotis Leonurus (Wild Dagga)
Leonotis leonurus is a species of shrub native to southern Africa with a long history of medicinal and recreational use. In this article I will investigate these usages, and the marketing of this substance.
The purpose of this article is not to recommend (or provide any opinion on) leonotis leonurus for any recreational or medicinal usage, only to provide information.
Wild dagga is know to induce euphoria, visual changes and sedation. This attracts some to use the substance for recreational purposes.
Relation to Cannabis?
While there is only a minimal biological relation between cannabis and wild dagga, the effects have some similarity.
Many have gone so far as to state that the effects of wild dagga are 'cannabis-like'.
Wild dagga is sold widely on the internet, often in products marketed as 'legal weed', 'legal bud' or as cannabis alternatives. Often these products include additional psychoactive herbs, to provide a more cannabis like effect.
Sales of wild dagga as a 'weed alternative' predate the Internet, with mail order companies selling the substance for this purpose since at least the last 70s.
Wild dagga is suspected of having antinociceptive, antiinflammatory, and hypoglycemic properties. Traditionally, and in modern alternative medicine it is used to help treat arthritic inflammation and type-2 diabetes mellitus.
- Academic Evaluation of "Buy Weed Online" Products
This site evaluates various 'legal bud' and 'buy legal weed' type products. Unlike similar sites it includes reputable citations for all claims. It acts as an effective aggregator of academic sources for the psychoactive effects of Wild Dagga.
- Erowid Leonotis leonurus (Lion's Tail) Vault
Information about Leonotis leonurus (Lion's Tail) including basics, effects, dosage, history, legal status, photos, research, media coverage, and links to other resources. Erowid is a respected source for subjective and anecdotal evidence, as well as more traditional sources.
No comments yet.